이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Near Vergence Training for Distance Control in Intermittent Exotropia

2026년 6월 10일 업데이트: LEUNG Tsz Wing, The Hong Kong Polytechnic University

Evaluating Near Vergence Training for Distance Control in Basic and Divergence Excess Intermittent Exotropia

Intermittent Exotropia (IXT) is a common type of eye misalignment where one eye periodically turns outward, and control is typically much worse when looking at objects far away than close up. However, most currently available training programme are focused on near-viewing tasks. The goal of this clinical trial is to investigate if a new, structured, home-based near eye training program works to improve distance eye alignment control in children and young adults with IXT.

The main questions the study aims to answer are:

  • Does a 12-week near eye training program improve a participant's ability to control their eye alignment when looking at a distance?
  • Does using a special reading glasses during near training help to control distance eye alignment better than doing the training without the reading glasses?
  • Do the benefits of this eye training last after the training has stopped?

This is a two- phase, single- masked (examiner masked), randomized clinical trial with crossover design. The entire study duration is about 24 weeks. A total sample size of 42 participants, aged 6 to 25 years with diagnosed Basic (distance deviation is within 10 prism diopters of the near deviation) or Divergence excess (distance deviation is at least 10 prism diopters greater than the near deviation) IXT, will be recruited.

In Phase I (Weeks 0 to 12), participants will be randomly allocated into one of three groups, with 14 individuals in each group:

  • Group 1 does eye training while wearing special plus-power reading glasses that remove the need to focus up close, mimicking how the eyes look at a distance.
  • Group 2 does the exact same eye training but wears regular distance glasses without the special reading addition.
  • Group 3 serves as a control group that does not do training during the first 12 weeks, but will receive the training in the second phase.

In Phase II (Weeks 13 to 24), which is a crossover phase, groups 1 and 2 will stop training to see if the visual improvements last, while group 3 will be re-randomized into two subgroups (group 3A, with special plus-power reading glasses, and group 3B with regular glasses with distance correction) that will undertake daily eye training for 12 weeks to ensure ethical treatment access. All participants will have a final eye exam at 24 weeks.

During home training, participants will:

  • Wear standard glasses provided by the study.
  • Practice daily, home-based eye exercises for 12 weeks using a standardized software program on a computer or tablet.
  • Complete 3 training sessions every day, lasting 7 minutes per session.
  • Wear red-blue 3D glasses during training and press arrow keys or swipe the screen to play a visual game that dynamically changes in difficulty.

Preliminary test and binocular vision assessment with fixed and uniform sequence will be performed at baseline visit, 6th week interim visit, 12th and 24th week evaluation. All eye examinations will be carried out in The Optometry Centre (A034), the School of Optometry, The Hong Kong Polytechnic University.

The following data will be statistically analyzed. The primary outcome data is distance Office Control Score (OCS) at 12-week visit. Secondary outcomes data include change in deviation angle, near and distance stereopsis and patient- / parent- reported health-related quality-of-life questions at 12-week.

연구 개요

연구 유형

중재적

등록 (추정된)

42

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

  • 이름: Horace Ho-yin Wong, MClinOptom, BSc (Hons) Optom
  • 전화번호: 852-63384048
  • 이메일: horace.wong@polyu.edu.hk

연구 연락처 백업

연구 장소

      • Hong Kong, 홍콩
        • 모병
        • The Optometry Clinic, The Hong Kong Polytechnic University
        • 연락하다:

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 어린이
  • 성인

건강한 자원 봉사자를 받아들입니다

아니

설명

Inclusion Criteria

  • Age and Diagnosis: Participants must be aged 6 to ≤ 25 years at the time of screening, with a confirmed clinical diagnosis of either Basic or Divergence Excess (DE) Intermittent Exotropia (IXT).
  • Ocular Alignment Magnitude: Distance exodeviation measuring between 10 and 40 prism diopters (pd) inclusive, determined by the prism and alternate cover test (PACT).
  • Distance-Near Disparity Limits: Near exodeviation must not exceed the distance exodeviation by more than 10 pd (to exclude Convergence Insufficiency type exotropia).
  • Baseline Distance Control: A baseline distance IXT Office Control Score (OCS) between Grade 2 and Grade 4 inclusive, based on the mean of 3 standardized assessments.
  • Baseline Near Control: A baseline near IXT control score less than or equal to the distance IXT control score, based on the mean of 3 standardized assessments.
  • Visual Acuity: Best-corrected visual acuity (BCVA) of Logarithm of the Minimum Angle of Resolution (logMAR) 0.1 or better in each eye at both distance and near fixation.
  • Sensory Status: Measurable near stereoacuity of 400 arc seconds or better on the Preschool Randot stereoacuity test.
  • Refractive Correction Stability: Compliance with wearing a stable, appropriate spectacle correction for ≥ 4 months prior to formal baseline assessment if the participant meets any of the following refractive thresholds:

    • Myopia < -0.50D spherical equivalent (SE) in either eye.
    • Hyperopia > +2.50D SE in either eye.
    • Anisometropia > 1.00 SE.
    • Astigmatism > 1.50D cylinder in either eye.
  • Treatment History: No history of prior non-surgical interventions for IXT, including patching, vision therapy/orthoptics, or overminus lens therapy (≥ 0.50 D).
  • Surgical History: No prior history of strabismus surgery, extraocular muscle botulinum toxin injections, intraocular surgery, or refractive surgery.
  • Trial Commitment: No planned strabismus surgery or conflicting ocular therapies during the 24-week study period.

Exclusion Criteria

  • Amblyopia and Co-morbid Strabismus: Presence of amblyopia, nystagmus, restrictive strabismus, or paretic strabismus.
  • Vertical Misalignment: Presence of an associated vertical ocular deviation > 5 pd.
  • Significant Pathologies: Co-existing significant ocular disease or neurological disorders (e.g., cerebral palsy) that could confound oculomotor or sensory evaluations.
  • Confounding Medications: Regular use of systemic or topical ocular medications known to alter accommodative or vergence function within the 3 months prior to screening (including, but not limited to, atropine, pirenzepine, or systemic anti-epileptic agents).

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 삼루타

무기와 개입

참가자 그룹 / 팔
개입 / 치료
활성 비교기: Active training group with reading glasses
Receiving training in Phase I (Weeks 0 to 12), stop training in Phase II (Weeks 13 to 24) to study the effect persistence
Standardized home-based near vergence training platform with data visualization tools and communication platforms
활성 비교기: Active training group without reading glasses
Receiving training in Phase I (Weeks 0 to 12), stop training in Phase II (Weeks 13 to 24) to study the effect persistence
Standardized home-based near vergence training platform with data visualization tools and communication platforms
간섭 없음: Control group
No training will be received in Phase I (Weeks 0 to 12); Will receive training in Phase II of the study (Weeks 13 to 24) to ensure ethical treatment access

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Change of Distance Office Control Score
기간: Baseline, 6-week, 12-week and 24-week
Objective and quantitative office control scale, based on the frequency of deviation and the recovery speed followed by occlusion. Ranged from 0 to 5, with score 0 represents the best control (phoria with excellent control), and score 5 represents the worst control (constant exotropia during the 30-second observation)
Baseline, 6-week, 12-week and 24-week

2차 결과 측정

결과 측정
측정값 설명
기간
Change of exodeviation magnitude angle
기간: Baseline, 6-week, 12-week and 24-week
measured by Prism and Alternate Cover Test, ranged from 1 to 50 prism diopter. The higher the value, the worse is the magnitude angle of the exodeviation
Baseline, 6-week, 12-week and 24-week
Change of Distance stereoacuity
기간: Baseline, 6-week, 12-week and 24-week
measured by Distance Randot® stereotest, ranged from 400 seconds of arc (the worst measurable stereoacuity) to 60 seconds of arc (the best measurable stereoacuity )
Baseline, 6-week, 12-week and 24-week
Change of Near stereoacuity
기간: Baseline, 6-week, 12-week and 24-week
measured by Preschool Randot® stereoacuity test, ranged from 800 seconds of arc (the worst measurable stereoacuity) to 40 seconds of arc (the best measurable stereoacuity )
Baseline, 6-week, 12-week and 24-week
Change of Quality of Life (QoL) measures - Chinese Intermittent Exotropia Questionnaire (CIXTQ) for children aged 5 to 17 and parents of children aged 2 to 17
기간: Baseline, 12-week and 24-week
Part a: Child CIXTQ - 12 items completed by children, simplified 3-point scale (0, 50 and 100); Part b: Proxy CIXTQ - 12 items completed by parents to evaluate their child's health-related quality-of-life (HRQoL) from a parental perspective, 5-point Likert-type (0, 25, 50, 75, and 100); Part c: Parent CIXTQ - 17 items to measure the parent's own HRQoL, 5-point Likert-type (0, 25, 50, 75 and 100). The higher the score, the better the outcome (QoL).
Baseline, 12-week and 24-week
Change of Quality of Life (QoL) measures - The Chinese Adult Strabismus Quality of Life Questionnaire (CAS-20) for adult participants aged 18 or above
기간: Baseline, 12-week and 24-week
20 items to assess psychosocial impact and visual function, 5-point Likert-type (0, 25, 50, 75 and 100). Higher scores indicating better perceived QoL.
Baseline, 12-week and 24-week

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 6월 1일

기본 완료 (추정된)

2028년 6월 1일

연구 완료 (추정된)

2028년 12월 1일

연구 등록 날짜

최초 제출

2026년 6월 3일

QC 기준을 충족하는 최초 제출

2026년 6월 10일

처음 게시됨 (실제)

2026년 6월 11일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 6월 11일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 6월 10일

마지막으로 확인됨

2026년 5월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • HSEARS20251213004

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

미정

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

Home-based near eye training program에 대한 임상 시험

  • Dartmouth-Hitchcock Medical Center
    Centers for Disease Control and Prevention
    완전한
    간질
    미국
  • Dartmouth-Hitchcock Medical Center
    Centers for Disease Control and Prevention
    완전한
    간질
    미국
구독하다